EyePoint Pharmaceuticals
EYPT
EYPT
66 hedge funds and large institutions have $69M invested in EyePoint Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.38% less ownership
Funds ownership: 5.8% → 5.43% (-0.38%)
29% less capital invested
Capital invested by funds: $97.2M → $69M (-$28.2M)
Holders
66
Holding in Top 10
1
Calls
$98K
Puts
$97K
Top Buyers
| 1 | +$4.22M | |
| 2 | +$514K | |
| 3 | +$511K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$154K |
| 5 |
IAN
Integrated Advisors Network
Dallas,
Texas
|
+$137K |
Top Sellers
| 1 | -$395K | |
| 2 | -$222K | |
| 3 | -$190K | |
| 4 |
GC
Grimes & Company
Westborough,
Massachusetts
|
-$153K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$145K |